Pharma/Biotech News
Subscribe to Pharma/Biotech News
View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Senior Pharmaceutical Executives Establish Business, next20

February 18, 2015 10:03 am | News | Comments

Three highly-experienced pharmaceutical and healthcare industry executives have formed next20, a new "Thought Partnership" which provides strategic support to help healthcare and pharmaceutical companies of all sizes identify and fully-leverage revenue opportunities. Read more...

Actavis Plans Corporate Name Change to Allergan

February 18, 2015 8:44 am | News | Comments

Actavis will change the company name after the completed acquisition of Allergan. Read more...                            

Lupin, Celon: Development, Licensing for Generic Advair Diskus

February 17, 2015 10:02 am | News | Comments

​Pharma Major Lupin Limited (Lupin) and Celon Pharma S.A. (Celon) announced that they have entered into a definitive agreement under which the companies will jointly develop a fluticasone/salmeterol dry powder inhaler (DPI) product which is a generic version of GlaxoSmithKline's Advair Diskus. Read more...


FDA Approves New Dosage for Noven's Osteoporosis Drug

February 13, 2015 11:05 am | News | Comments

The new dosage is now available by prescription nationwide. Read more...                               

Scientists Limit Accelerated Cellular Aging Caused by Methamphetamine Use

February 13, 2015 10:41 am | by UC Irvine | News | Comments

The ravaged faces of methamphetamine addicts tell a terrible tale – abusing the drug dramatically accelerates aging. Read more...                      

Drug Abuse in Iran Rising Despite Executions, Police Raids

February 13, 2015 10:34 am | by Ali Akbar Dareini - Associated Press | News | Comments

Officials say methamphetamine production and abuse of hard drugs are skyrocketing in the country despite potentially lethal criminal penalties for users if they are caught. Read more...            

Eisai's Thyroid Cancer Drug: Phase 3 Trial

February 12, 2015 11:38 am | News | Comments

Results from the pivotal Phase 3 SELECT (Study of (E7080) Lenvatinib in Differentiated Cancer of the Thyroid) trial evaluating the use of investigational agent lenvatinib in the treatment of progressive, radioactive iodine-refractory differentiated thyroid cancer (RAI-refractory DTC) were published online in the New England Journal of Medicine (NEJM). Read more..

Cumberland Pharmaceuticals: Pipeline Expansion with AERD Drug

February 12, 2015 11:10 am | News | Comments

Cumberland Pharmaceuticals Inc. announced an expansion of its pipeline with a new Phase II development program. The Company has initiated the clinical development of Boxaban (ifetroban) oral capsule for the treatment of aspirin exacerbated respiratory disease (AERD). Read more..


J&J Projects Aim to Spot Who'll Get a Disease

February 12, 2015 10:59 am | by Associated Press | News | Comments

Imagine being able to identify people likely to develop a particular disease - and then stop it before it starts. This isn't a science fiction tale. It's the ambitious goal of three research projects just launched by Johnson & Johnson's pharmaceutical research arm, Janssen Research & Development, that the company says are aimed at redefining health care. Read more...

AbbVie Submits NDA in Japan for Hepatitis C Treatment

February 12, 2015 8:46 am | News | Comments

The NDA is supported by positive results from a Phase 3 study. Read more...                               

Qiagen's Tuberculosis Treatment Preferred in Large Study

February 11, 2015 4:49 pm | News | Comments

Groundbreaking clinical data published in the The Lancet medical journal showed that reliance on the 100-year-old tuberculin skin test has significantly overestimated latent tuberculosis infections in China, while results in the same patients using the QuantiFERON-TB Gold (QFT) from QIAGEN N.V. provided a far better understanding of disease burden. Read more...

Rite Aid Spends $2B on Push Into Pharmacy Benefit Management

February 11, 2015 10:45 am | News | Comments

Drugstore chain Rite Aid will use a $2 billion purchase of EnvisionRx to stretch its reach into managing pharmacy benefits in a deal that also builds its stake in two hot growth areas, specialty pharmaceuticals and Medicare prescription drug coverage. Read more...

Roche Acquires Signature Diagnostics to Enhance Genomic Research Efforts

February 10, 2015 12:19 pm | News | Comments

The amount of money paid for Roche's new acquisition is unknown. Read more...                               


Specialty Drugs Help CVS Health Meet 4Q Profit Forecasts

February 10, 2015 12:13 pm | by Tom Murphy - AP Business Writer | News | Comments

The company said that growing demand for expensive specialty drugs helped increase revenue from its pharmacy benefits management. Read more...                    

Reducing Animal Testing One Chip at a Time

February 10, 2015 9:19 am | by Michelle Taylor, Editor-in-Chief, Lab Equipment | Articles | Comments

Speaking to a room of pharmaceutical scientists, Donald Ingber started off his Keynote presentation at SLAS 2015 in Washington D.C. by saying that “the current drug development model is broken.” He pointed to Eroom’s Law (Moore’s law backward) as proof. Read more...

Achillion Shares Soar Following Hepatitis C Drug Update

February 9, 2015 11:57 am | by Associated Press | News | Comments

Shares of Achillion Pharmaceuticals Inc. jumped Monday morning after the drug developer said a small group of patients who took its experimental hepatitis C treatment combination remained free of the liver-destroying virus three months after they stopped taking doses. Read more...

Supplements Industry Derides NY Attorney General's DNA Tests

February 9, 2015 11:32 am | by Mary Esch, Associated Press | News | Comments

DNA barcoding has exposed some infamous cases of food fraud, like cheap catfish sold as pricey grouper and expensive "sheep's milk" cheese that was really made from cow's milk. But can it tell if a pill touted as an energy-booster contains ginseng or is just a mix of rice powder and pine? Read more...

Pfizer Acquisition of Hospira Lays Foundation for Potential Generics Unit Spin-off

February 6, 2015 2:06 pm | by Pfizer | News | Comments

Adam Dion, MS, GlobalData’s Healthcare Industry Analyst, says: “On 5 February 2015, just days after gaining US Food and Drug Administration (FDA) breakthrough approval for Ibrance (palbociclib) in breast cancer, Pfizer entered into an agreement to purchase generic drug maker Hospira for $90 per share in cash, or approximately $17 billion, representing about a 40 percent premium above Hospira’s stock price." Read more...

Getting Ahead of Antibiotic Resistant Bacteria

February 6, 2015 9:01 am | by Colin Poitras, University of Connecticut | News | Comments

The prevalence of antibiotic-resistant bacteria has turned new drug development into a high-stakes chess game, with researchers always trying to anticipate a disease bacteria’s next move or mutation. Read more...        

Diamonds Could Help Bring Proteins into Focus

February 6, 2015 8:56 am | by David L. Chandler - MIT | News | Comments

A new technique shows great promise for producing highly detailed images of individual proteins. Read more...                         

How Outgoing FDA Chief Oversaw Food, Drugs and Tobacco

February 6, 2015 8:41 am | by Associated Press | News | Comments

FDA Commissioner Margaret Hamburg announced Thursday that she will step down next month after nearly six years overseeing the agency, which regulates products making up 25 percent of the U.S. economy. Read more...       

Vaccine Skeptics Find Unexpected Allies in Conservative GOP

February 6, 2015 8:34 am | by Nicholas Riccardi - Associated Press | News | Comments

As vaccine skeptics fight laws that would force more parents to inoculate their kids, they are finding unexpected allies in conservative Republicans. Read more...                 

The Longevity of Attention Deficit Drugs

February 5, 2015 5:09 pm | by Stephanie Guzowski, Editor | Articles | Comments

Can A.D.H.D. drugs help “normalize“ a child’s brain? Recent research suggests that A.D.H.D. medication may regulate the brain over time, rewiring neural connections, so that the focus and in-control effect endures. Read more...

FDA Accepts Actavis' sNDA for Teflaro Labeling Expansion

February 5, 2015 4:03 pm | News | Comments

The FDA has set a target of Q3 2015 to complete its review of the medication. Read more...                             

Hackers Access Records for Millions of Anthem Customers

February 5, 2015 11:07 am | by Tom Murphy - AP Business Writer | News | Comments

The nation's second-largest health insurer said it was contacting customers affected by what it calls a very sophisticated cyberattack that the company discovered last week. Read more...             

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.